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Suspected chyle leak during 
complex spine surgery
A unique case of propofol 
infusion resulting in lipid 
emulsion pooling in the 
surgical field
ABSTRACT
The authors report a case of propofol infusion being mistaken for chyle during a two stage thoracic spinal fusion. Propofol 
is commonly used during spine surgery to facilitate neuromonitoring and there are no reported cases of these observations 
in the spine literature. We describe the positioning, timing, and treatment in a patient that required prolonged care to rule 
out a chylothorax.  Chyle and the pharmacologic and physiologic effects of propofol are discussed. This review outlines 
our reasoning and steps used to rule out a chyle leak in the setting of propofol-based anesthesia.
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Introduction
Intravenous propofol infusion is often 
used to provide anesthesia for pati-
ents undergoing surgical procedures 
requiring motor evoked potential (MEP) 
monitoring.  We present a unique case 
in which high - dose propofol - given 
over a prolonged period of time - resul-
ted in lipid emulsion pooling in the 
operative field during elective bilateral 
extracavitary excision of T7 with poste-
rior instrumentation. 
Case presentation
A 22 year old, 170 cm, 85 kg female 
presented with thoracic myelopathy 
due to a T7 hemivertebrae.  Following 
a history, physical exam, and imaging 
she was scheduled for a bilateral extra-
cavitary excision of T7 with posterior 
instrumentation, requiring prone positi-
oning for several hours.  When placed 
in the prone position, the patient’s neu-
romonitoring status showed no motor 
signals in her legs and very faint signals 
in her arms.  Without neuromonitoring, 
it was felt that the patient would be at 
increased risk for cord ischemia.  The 
operative plan was therefore changed 
to a limited right posterolateral thora-
cotomy and excision of the anterior 
hemivertebrae.  
Four days later, she underwent an 
uncomplicated right thoracotomy and 
excision of the anterior hemivertebrae 
with MEP monitoring.  Anesthesia time 
for the first stage was 370 minutes, of 
which 240 minutes involved maintenan-
ce with a continuous propofol infusion 
(100-250 mcg/kg/min).  Chest tube pla-
cement, to suction overnight, revealed 
minimal serosanguineous drainage. 
Two days later, a second stage poste-
rior extracavitary excision of the hemi-
vertebrae and stabilization with percu-
taneous pedicle screw instrumentation 
was performed with MEP monitoring. 
Anesthesia time for the second stage 
was 607 minutes, of which 547 minutes 
involved maintenance with a continu-
ous propofol infusion (175-225 mcg/
kg/min).  While excising the vertebrae 
it was noted that, after the left pedicle 
and part of the vertebral body were 
removed,  a white “milky” substance 
was beginning to pool at the bottom of 
the surgical cavity.  Thoracic surgery 
was consulted intraoperatively and they 
believed that this was a potential chyle 
leak.  The remainder of the operation 
was completed without complication. 
Chest tube and surgical drain (placed 
adjacent to the site of the suspected 
chyle leak) output was monitored for 5 
days. Because of the suspected chyle 
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leak, parenteral nutrition with short and 
medium chain fatty acids was initiated 
immediately postoperatively.  Postope-
ratively, no chyle was visible in the drain 
or chest tube.   Pleural fluid analysis 
revealed a triglyceride concentration of 
67 mg/dl, which is below the concentra-
tion (>110 mg/dl) indicative of a chylo-
us effusion.  Trials of whole milk and 
other liquids that contained long chain 
fatty acids did not result in increased 
chest tube and surgical drain output, 
or chylous appearance.  The surgical 
drain and chest tube were discontinued 
on postoperative day (POD) #5 and 
POD #6, respectively.  
Discussion
Anesthesia and During Motor Evoked 
Potential Monitoring
For decades, somatosensory evoked 
potentials (SSEP) were considered the 
gold standard monitoring tool for asse-
ssing the integrity of neuronal pathways 
in patients undergoing spine (or plexus) 
surgery during general anesthesia. 
(1)  However, numerous case reports 
emerged during this time describing 
motor pathway injury despite normal 
intraoperative SSEP monitoring. (1) As 
a result, MEP monitoring was deve-
loped to assess anterior descending 
motor pathways. (1,2) Unfortunately, 
previous animal- and human-based 
studies reported dramatic deterioration 
of traditional analog MEPs with even 
scant amounts of inhaled (e.g., isoflura-
ne) or many intravenous (e.g., propofol) 
anesthetics thereby precluding intelli-
gible data acquisition during general 
anesthesia using these options. (3) 
During the early stages of MEP develo-
pment, the anesthesia armamentarium 
typically consisted of one or more of 
the following intravenous medications: 
opioid, benzodiazepine, ketamine, and 
muscle relaxant (when appropriate). 
However, these anesthetics were often 
cumbersome to administer and raised 
concerns about intraoperative aware-
ness and prolonged emergence. (3)  
The next generation of MEP moni-
tors, incorporating digital processing, 
demonstrated less erroneous interpre-
tation due to the pharmacophysiologic 
effects of intravenous propofol and low-
dose isoflurane.  This has simplified 
anesthetic management of these types 
of cases and lessened the concerns of 
intraoperative awareness and delayed 
emergence.  Currently at our institution, 
we typically provide total intravenous 
anesthesia with combined propofol and 
opioid infusions during acquisition of 
baseline signals.  Subsequently, inha-
led volatile anesthesia may be titrated 
in as tolerated by the MEP signal res-
ponse.  It is imperative to avoid drama-
tic changes in the level of anesthesia 
(intravenous or inhaled) during the criti-
cal period(s) of surgery (e.g., spine dis-
traction) so as to avoid falsely positive 
signal changes.  
Propofol Anesthesia
Propofol is a hypnotic agent that is 
commonly used for induction and 
maintenance of anesthesia.  Propofol 
(2,6-diisopropofol ) is the most frequ-
ently used intravenous anesthetic in 
current use. (4) The current formulation 
consists of 1% (wt/vol) propofol, 10% 
soybean oil, 2.25% glycerol, and 1.2% 
purified egg phosphatide. (5) The oil 
portion is 10% or 100 mg/mL of fat. 
This is much higher than the normal 
triglyceride level which is 1.5 mg/mL or 
150 mg/dL.  Serum triglyceride levels 
of more than 10 mg/mL or 1000 mg/dL 
have been know to cause pancreatitis 
and lead to propofol infusion syndrome 
(PRIS).  The hypnotic action of propo-
fol is mostly mediated by enhancing 
-aminobutyric acid (GABA)–induced 
chloride current through its binding to the 
-subunit of the GABAA receptor.  Sites 
on the 1-subunit (M 286), 2-subunit 
(M 286), and 3-subunit (N265) of the 
transmembrane domains are crucial 
for the hypnotic action of propofol. (5) 
The -subunit and 2-subunit subtypes 
also seem to contribute to modulating 
the effects of propofol on the GABA 
receptor.  Propofol, through its action 
on GABAA receptors in the hippocam-
pus, inhibits acetylcholine release in the 
hippocampus and prefrontal cortex. (5) 
The 2-adrenoreceptor system also 
seems to play an indirect role in the 
sedative effects of propofol. (4) Pro-
pofol results in widespread inhibition 
of the N-methyl-D-aspartate (NMDA) 
subtype of glutamate receptor through 
modulation of sodium channel gating, 
an action that also may contribute to the 
drug’s central nervous system (CNS) 
effects.  Studies have shown that pro-
pofol has a direct depressant effect on 
neurons of the spinal cord. (5) In regard 
to neuromonitoring, the motor pathways 
and MEPs are susceptible to anesthetic 
agents at three sites along the neuraxis: 
motor cortex, anterior horn cells, and 
the neuromuscular junction. (2)  
In the clinical setting, several infusion 
schemes have been used to achieve 
adequate plasma concentrations of 
propofol. (5) Maintenance dose infusi-
on rates necessary to achieve surgical 
anesthesia typically range from 100 to 
200 g/kg/min. (5)  
Patients (frequently pediatric, rarely 
adults) receiving high-dose long-term 
(exceeding 48 hours) propofol infu-
sions, may demonstrate a rare con-
stellation of symptoms referred to as 
the PRIS. (6,7) PRIS is defined as the 
occurrence of bradycardia recalci-
trant to therapy and progressing to 
asystole, lipemic plasma, fatty liver 
enlargement, metabolic acidosis with 
base deficits exceeding 10 mmol/l, 
rhabdomyolysis or myoglobinuria. (7) 
The lipemia is likely due to failure of 
hepatic lipid regulation, possibly rela-
ted to poor oxygenation or low glucose 
plasma concentrations.  Lipemia could 
lead to sequestration of propofol into 
the lipid phase thereby decreasing 
free propofol levels (i.e., the pharma-
cologically active form of the drug) 
and apparent insensitivity to propofol. 
(6,7)  Fat overload associated with 
propofol infusions may also contribute 
to increased free fatty acids. (6,7)  Fat 
metabolism analysis of patients with 
PRIS resemble those found in pati-
ents with mitochondrial cytopathies, 
acquired acyl-carnitine metabolism 
deficiencies, hereditary mitochondri-
al fatty acid metabolism impairment 
resembling medium-chain acyl-CoA 
dehydrogenase deficiency, or low car-
bohydrate supply (because energy 
demand is satisfied by lipolysis if car-
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bohydrate supply is low). (6,7) In some 
cases, lipemia was the first indication 
of impending PRIS. (6,7)  
There is really only one case reported 
in the literature of propofol mimicking 
a chyle leak.  Vokes, in 2006, noticed 
a milky substance in a neck dissection 
for a recurrent cervical chordoma with 
multiple masses. (4) About 6 hours after 
anesthesia was begun they visualized a 
milky fluid and they had already tied off 
the thoracic duct and no leak was found 
in that area.  They knew the patient had 
not eaten for several hours before sur-
gery and doubted that chyle was lea-
king.  They observed that the substan-
ce was coming from multiple bleeding 
areas and was separating itself from 
the blood.  The propofol rate was 350 
mcg/kg/min during surgery and they 
drew a syringe full of the substance 
and blood which layered out after 20 
minutes.  They also sent a sample for 
analysis and it had a triglyceride level of 
>100 mg/mL (or 10,000 mg/dL).  They 
recommended aspirating a sample of 
suspected fluid, chyle or propofol, and 
having it sit to separate.  They also sent 
samples for analysis to detect the trigl-
yceride level.  
Chyle
Chyle is lymph fluid which is usually a 
milky substance found in the thoracic 
duct and other lymph vessels draining 
the enteric system.  It is produced after 
eating a fatty meal and contains chylomi-
crons from long chain triglycerides and 
lymphocytes in an electrolyte balance 
similar to plasma.  The milky color cle-
ars after fasting and returns rapidly after 
eating fat containing meals.  Leakage 
of chyle, usually iatrogenic in origin at 
the time of an intrathoracic procedure, 
can lead to an intrathoracic collection 
termed chylothorax.  Left unrecognized, 
a chylothorax can lead to respiratory 
compromise, nutritional depletion and 
a relative immunocompromised state 
due to loss of immunoglobulins from 
the systemic circulation.  Leaks are 
commonly treated with oral fasting and 
parenteral nutrition to allow the low pre-
ssure system to seal. In general, this 
can take approximately one week to 
resolve such that normal oral feeding 
can resume without reoccurrence of the 
chylothorax.   
Propofol mimicking chyles leaks has 
not been reported in the spine literature. 
Due to the large volume of cases being 
performed using propofol and narcotics 
as the anesthetic, it is worth reviewing 
this situation to educate others of the 
potential misdiagnosis when one entity 
is mistaken for the other.  Chyle can 
range from 400 mg to 6000 mg/dL of 
fat depending on the proximity to a high 
fat meal and is often considered in the 
differential diagnosis when high volume 
outputs are recorded persistently from 
intrathoracic drains.  With continued 
fasting, lymph fluid from a chylothorax 
becomes more serous in nature as its 
high lipid content progressively decre-
ases.  Propofol has a concentration of 
10,000 mg/dL of fat and can appear 
very similar to fat.
Putting it all together
After reviewing the situation and the 
literature, several points can be made 
to support our belief that the fluid was 
propofol.  First, the initial stage of the 
operation was performed via a right 
sided thoracotomy.  Although injury to 
the thoracic duct can occur with a right 
sided thoracotomy, it more commonly 
occurs after a left sided procedure. 
Second, we noticed the “milky substan-
ce” while posteriorly entering the left 
hemithorax during the second stage of 
her operation, after the patient was nil 
per os for 72 hours. In a fasting patient, 
the presence of “milky fluid” occurring 
in the opposite hemithorax of the initial 
operation, that could not be manifested 
radiographically, clinically or by quanti-
tative drain output analysis by provoca-
tive postoperative lipid loading maneu-
vers, suggests that the “milky fluid” was 
likely propofol extravasation into the 
surgical cavity.  In our case, our patient 
did not manifest the clinical aberrations 
typically associated with PRIS.  Howe-
ver, due to the prolonged nature of her 
surgeries performed under anesthesia 
maintained with a high propofol infusi-
on rate, hepatic and extrahepatic lipid 
regulation may have been impaired 
thereby leading to lipemia.  
